Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, In Silico Trials

The variability in clinical trial results on memantine treatment of Alzheimer’s disease remains incompletely explained. The aim of this in silico study is a virtual memantine therapy for Alzheimer’s disease that provides a different perspective on clinical trials; An in silico randomised trial using...

Descripción completa

Detalles Bibliográficos
Autores principales: Świetlik, Dariusz, Białowąs, Jacek, Kusiak, Aida, Krasny, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145937/
https://www.ncbi.nlm.nih.gov/pubmed/35631372
http://dx.doi.org/10.3390/ph15050546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145937/
https://www.ncbi.nlm.nih.gov/pubmed/35631372
http://dx.doi.org/10.3390/ph15050546

Ejemplares similares